Monitor for potential pipeline acceleration given Knight's oncology development background, but no immediate financial impact expected from this personnel change.
Price Chart
Executive Summary
ALX Oncology appointed Jeff Knight as Chief Development and Operating Officer on April 13, 2026, with an annual base salary of $565,000 and a stock option grant to purchase 800,000 shares. The announcement was made via a press release furnished under Item 7.01.
Key Facts
- Jeff Knight appointed as Chief Development and Operating Officer effective April 13, 2026
- Annual base salary set at $565,000 with eligibility for a 40% target cash bonus
- Received stock option to purchase 800,000 shares, vesting 25% on first anniversary and monthly thereafter
- Entered into standard change of control and severance agreement
- Announcement made through press release under Item 7.01
Financial Impact
Compensation package includes $565,000 annual base salary and equity grant valued at approximately $4.5 million based on current market price
Risk Factors
- Integration risk with existing management team
- Failure to execute on upcoming clinical catalysts despite new leadership
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-152050 |
| Document: alxo-ex99_1.htm | 0001193125-26-152050 |
| Document: 0001193125-26-152050-index-headers.html | 0001193125-26-152050 |
| Document: 0001193125-26-152050-index.html | 0001193125-26-152050 |
| Document: 0001193125-26-152050.txt | 0001193125-26-152050 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | SC 13D/A | $1.14 $1.13 | ▼ −0.88% | ▼ −0.73% | $1.17 (+2.63%) |
Oct 15, 2026 11d ago | 8-K | $1.06 $1.17 | ▲ +10.38% | ▲ +10.81% | $1.17 (+10.38%) |
Sep 28, 2026 28d ago | Press Release | $1.39 $1.21 | ▼ −12.95% | ▼ −14.15% | $1.17 (−15.83%) |
Aug 15, 2026 10w ago | Institutional Cluster | $1.97 $1.99 | ▲ +1.02% | ▲ +2.21% | $1.17 (−40.61%) |
Aug 6, 2026 11w ago | 8-K | $2.11 $1.94 | ▼ −8.06% | ▼ −9.27% | $1.17 (−44.55%) |
Jun 30, 2026 16w ago | 8-K | $2.06 $2.36 | ▲ +14.56% | ▲ +14.30% | $1.17 (−43.20%) |
Jun 26, 2026 17w ago | 8-K | $2.20 $2.19 | ▼ −0.45% | ▼ −1.84% | $1.17 (−46.82%) |
Jun 12, 2026 19w ago | Institutional Cluster | $1.58 $1.53 | ▲ +3.16% | ▲ +3.84% | $1.17 (+25.95%) |
May 8, 2026 24w ago | 8-K | $2.08 $2.04 | ▼ −1.92% | ▼ −3.39% | $1.17 (−43.75%) |
May 8, 2026 24w ago | Press Release | $2.08 $2.04 | ▲ +1.92% | ▲ +3.39% | $1.17 (+43.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers